End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,172 KRW | -0.59% |
|
-1.68% | +3.17% |
Business Summary
Number of employees: 22
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Development Technology Product
90.3
%
| 14,665 | 87.7 % | 23,505 | 90.3 % | +60.28% |
Research Service
6.5
%
| 1,381 | 8.3 % | 1,692 | 6.5 % | +22.49% |
Royalty
3.2
%
| 682 | 4.1 % | 835 | 3.2 % | +22.45% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 16,729 | 100.0 % | 26,033 | 100.0 % | +55.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hun-Sik Wang
CEO | Chief Executive Officer | 52 | 02-07-31 |
Jun-Sang Park
CTO | Chief Tech/Sci/R&D Officer | 52 | 02-07-31 |
Dae-Jong Park
AUD | Comptroller/Controller/Auditor | 51 | 15-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hun-Sik Wang
CEO | Chief Executive Officer | 52 | 02-07-31 |
Jun-Sang Park
CTO | Chief Tech/Sci/R&D Officer | 52 | 02-07-31 |
Jae-Kyung Park
BRD | Director/Board Member | - | - |
Dong-Hwan Kim
BRD | Director/Board Member | 48 | - |
Yong-Beom Kim
BRD | Director/Board Member | 44 | 20-03-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,699,394 | 62,495,823 ( 81.48 %) | 20 ( 0.000026 %) | 81.48 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GL PHARM TECH CORP. 0.00% | 20 | 0.00% | 17 $ |
Company contact information
GL Pharm Tech Corp.
Unit 714, Jungang Induspia Wing 5 137 Sagimakgol-ro
13202, Seongnam-si
+
http://www.glpt.co.kr![address GL Pharm Tech Corp.(A204840)](https://cdn.zonebourse.com/static/address/120973765.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+3.17% | 65.62M | |
+48.17% | 57.87B | |
+41.65% | 40.25B | |
-6.80% | 39.94B | |
-5.96% | 28.54B | |
+12.69% | 26.4B | |
-20.47% | 19.33B | |
+31.22% | 12.4B | |
+0.10% | 12.23B | |
+24.85% | 12.2B |
- Stock Market
- Equities
- A204840 Stock
- Company GL Pharm Tech Corp.